Medical vs commercial weight-loss programs: who supervises, what the evidence shows for behavioral programs and medication, dated cost ranges, insurance and how to decide with your clinician.
Fact-checked against FDA labels and official sources; not yet reviewed by a licensed clinician. This page is education, not medical advice. Talk to your doctor before starting, stopping or changing any treatment.
Key takeaways
- Intensive behavioral programs led to about 2.39 kg more weight loss than control at 12-18 months and nearly doubled the chance of losing 5% (USPSTF).[1]
- In the Diabetes Prevention Program, lifestyle change lowered the risk of type 2 diabetes by 58% vs placebo, and metformin by 31%.[3]
- In their main trials, Wegovy and Zepbound led to 14.9% and 20.9% average weight loss with lifestyle support, vs 2.4% and 3.1% on placebo.[9]
- After stopping Wegovy in the STEP 1 extension, participants regained about two thirds of the weight lost within a year.[11]
- Medicare covers intensive behavioral counseling for obesity in primary care at no cost when the provider accepts assignment.[14]
In short: Commercial programs such as WeightWatchers, Noom, Nutrisystem, Jenny Craig and Optavia (now Trilivy) help with food, habits and support, and cost roughly $12 to $70 a month for app programs or more for delivered food. Medical programs are run or supervised by licensed clinicians, can treat weight-related conditions, and may add prescription medication, which in trials led to much larger average weight loss but costs more and has more side effects. Neither is “better” for everyone: the right route depends on your health, your goals and your budget, and is best decided with a doctor after an evaluation.
This guide is information only and not a recommendation for any company. InstaTuck has no affiliate links on this page. Talk with a licensed doctor, get evaluated, and do your own research before starting any program, medication or procedure.
Key numbers
- -2.39 kgextra weight lost with intensive behavioral programs vs control at 12-18 months (67 trials)USPSTF evidence summary
- 8people who need a behavioral program for one more person to reach 5% weight lossUSPSTF evidence summary
- 58%lower chance of type 2 diabetes with the DPP lifestyle program vs placebo after about 3 yearsNIDDK
- 14.9-20.9%average weight loss in the main trials of Wegovy and Zepbound, with lifestyle supportNEJM, STEP 1 and SURMOUNT-1
Checked on October 6, 2026
The three routes, in plain words
- Commercial programs sell an eating system, food, an app, coaching or group support. Examples: WeightWatchers (Points and Workshops), Noom (psychology lessons), and food-based programs Nutrisystem, Jenny Craig and Optavia (now Trilivy). Coaches are usually not licensed clinicians.
- Medical programs are led by licensed clinicians: your primary care doctor, an obesity medicine specialist, a hospital program or a weight-loss clinic. They start with an evaluation, can order tests, manage conditions such as diabetes or high blood pressure, and may use medication or refer for bariatric surgery.
- Hybrid and telehealth programs sit in between: online clinicians who prescribe (such as Ro or Hims and Hers), or commercial brands with a medical tier (WeightWatchers Med+, Noom Med). Our telehealth guide lists what to check.
Side by side
| Question | Commercial program | Medical program (in person or telehealth) |
|---|---|---|
| Who guides you? | Coaches, group leaders, an app; sometimes dietitians | Licensed clinicians (MD, DO, NP or PA), often with dietitians and behavioral specialists |
| Medical evaluation? | No; you are asked to check with your doctor | Yes: history, medicines, often labs; telehealth relies more on questionnaires |
| Prescribes medication? | No (unless it has a separate medical tier) | May prescribe FDA-approved medicines when appropriate |
| Manages other conditions? | No | Yes, for example diabetes, blood pressure, sleep apnea |
| Typical cost (checked 2026-10-06) | About $12-$70 a month for apps; food programs more | Visits (often billed to insurance) or $74-$149 a month telehealth memberships, plus medication |
| Insurance | Rarely covered | Visits may be covered; medication coverage varies by plan |
| Main trade-off | Lower cost and risk, smaller average weight loss | Larger average weight loss with medication, more cost, side effects and monitoring |
What the evidence says about behavioral and commercial programs
The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians offer or refer adults with a BMI of 30 or more to intensive, multicomponent behavioral programs (grade B, 2018). In its evidence review, people in behavioral programs lost on average 2.39 kg (about 5.3 lb) more than control groups at 12 to 18 months, across 67 trials and more than 22,000 people, and were almost twice as likely to lose 5% of their weight (risk ratio 1.94). Most effective programs lasted 1 to 2 years and had 12 or more sessions in the first year. The task force found the harms of these programs to be small to none.
Commercial programs have been tested directly too. A 2015 systematic review in the Annals of Internal Medicine found WeightWatchers led to at least 2.6% more weight loss than control at 12 months and Jenny Craig at least 4.9%; Nutrisystem showed at least 3.8% at 3 months, and very-low-calorie programs including Medifast at least 4.0% in the short term, fading after 6 months. Large trials in primary care found people referred to WeightWatchers lost about twice as much as with standard care (5.06 vs 2.25 kg at 12 months).
Modest numbers can still matter for health. In the Diabetes Prevention Program, adults at high risk who aimed to lose 7% of their weight with diet changes and 150 minutes of activity a week lowered their chance of developing type 2 diabetes by 58% compared with placebo, while metformin lowered it by 31%.
| Item | Value |
|---|---|
| Lifestyle change program | 58% |
| Metformin | 31% |
After about 3 years, in adults at high risk of type 2 diabetes.
Source: NIDDK, Diabetes Prevention Program (DPP) (checked on October 6, 2026)
What the evidence says about medical treatment with medication
Newer medicines produced much larger average weight loss in their main trials, always together with diet and activity counseling. In STEP 1, adults on Wegovy 2.4 mg lost 14.9% of their weight at 68 weeks vs 2.4% on placebo. In SURMOUNT-1, those on the highest dose of Zepbound lost 20.9% at 72 weeks vs 3.1%. In OASIS 4, the Wegovy pill (25 mg) led to 13.6% vs 2.2%. These are averages: some people lose much more, some much less, and some stop because of side effects.
Medication brings its own considerations. FDA labels list common digestive side effects, serious risks such as pancreatitis and gallbladder problems, and, for GLP-1 medicines, a boxed warning about thyroid C-cell tumors with a contraindication for people with a personal or family history of medullary thyroid cancer or MEN 2. In trials, much of the weight came back after people stopped: one year after stopping Wegovy in the STEP 1 extension, participants had regained about two thirds of the weight they had lost. That is why medical programs treat obesity as a long-term condition and plan for maintenance. Note also that the USPSTF review (2018) predates the newest medicines; at that time it encouraged clinicians to make behavioral programs the primary focus because medication trials had selective enrollment, high dropout and little data after stopping.
What each route costs (checked 2026-10-06)
| Item | Low | High |
|---|---|---|
| Commercial app programs (Noom Weight, by plan length) | $17.5 USD | $70 USD |
| Telehealth memberships (WeightWatchers Med+, Ro, Hims) | $74 USD | $149 USD |
| Brand GLP-1 medicine, manufacturer self-pay | $149 USD | $449 USD |
| Telehealth membership plus self-pay medicine | $223 USD | $598 USD |
Last row is our arithmetic (lowest membership plus lowest medicine, highest plus highest). WeightWatchers Core starts at $12 a month on a 12-month plan. Insurance can lower medicine costs a lot.
Source: Noom pricing article; WeightWatchers Med+; Ro and Hims (Internet Archive captures, 2026-10-03 and 2026-10-01); NovoCare and Lilly self-pay pages (checked on October 6, 2026)
- Medicare: covers obesity screening and intensive behavioral counseling in primary care for people with a BMI of 30 or more, at no cost when the provider accepts assignment. The temporary Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027) covers certain GLP-1s for weight management with a $50 copay for those who qualify.
- Taxes: the IRS lets you count fees for a weight-loss program that treats a disease diagnosed by a physician, such as obesity, as a medical expense, but not diet food that replaces normal meals or general gym dues. That can matter for HSA and FSA spending.
- Total cost: count everything for a full year, including food you still buy, lab tests, visits and maintenance. Our costs hub, insurance hub and GLP-1 cost tool help.
How to decide: do these next 1-2-3
A simple way to choose
- Know your numbersCheck your BMI and waist with the BMI calculator and list any weight-related conditions, such as prediabetes, high blood pressure or sleep apnea.
- See a clinicianAsk for an evaluation and whether a behavioral program alone, medication, or another treatment fits you. Bring the questions on this page.
- Pick and reviewChoose a program you can afford and stick with for at least 6 to 12 months, then review progress with your clinician at set times.
Some general patterns, to discuss with your doctor rather than to decide alone:
- A commercial or behavioral program is often a reasonable first step for people who want to lose a modest amount, have no major weight-related conditions, or want to build habits that last. The NIH suggests a realistic first goal of 5 to 10% of your weight within about six months.
- A medical program is worth asking about when you have conditions linked to weight, take medicines affected by weight change, have tried structured programs before without lasting results, or fall in the group the NIH says medicines are generally considered for: adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
- Many people combine both: the FDA labels approve weight-loss medicines together with a reduced-calorie diet and more physical activity, and several commercial programs now have a medical tier for exactly that reason.
Keeping it off, on either route
The NIH says a safe and successful program should include a plan for keeping the weight off. With food-based programs, the hard part is going back to ordinary meals; with medication, it is what happens if you stop. Ask any program what its maintenance phase looks like and how long support lasts. Our keep it off hub and after a GLP-1 guide cover the habits linked with maintaining weight loss, and strength training helps protect muscle on any plan.
For more, see the programs hub, the weight-loss medications hub, our guide to losing weight and Find My Options.
Our disclosure
InstaTuck has no affiliate agreement with any program named here and earns nothing from this page. We compare programs on published evidence and dated prices only, and never name a “winner”. Read our editorial standards.
Related guides
Weight-Loss Programs: commercial, telehealth and clinical comparedWeight-loss programs compared: commercial, app, meal-delivery, telehealth and clinical programs, what to check before signing up,…
Medical Weight Loss: physician-supervised options explainedMedical weight loss explained: who provides it, what a visit and labs include, programs, medications, procedures,…
Keep It Off: how to maintain weight loss for the long termHow to maintain weight loss: what long-term maintainers do, calories after weight loss, protein and strength,…
Telehealth Weight-Loss Programs: how online GLP-1 care works and what to checkTelehealth weight-loss programs explained: how online GLP-1 care works, licensing, approved vs compounded medicines, pharmacy checks,…Tools for this topic
BMI Calculator for Adults (and what BMI cannot tell you)Free BMI calculator for adults with CDC categories, plus what BMI cannot tell you, why waist…
Find My Options: see the weight-loss approaches that match your preferencesFind My Options: a private, five-step questionnaire that shows the weight-loss approaches matching your goals and…Latest research
Weight-Loss Devices FDA Has Authorized: Balloons, Capsules and MoreEvery weight-loss device the FDA has authorized, from the Lap-Band to swallowable balloons and gel capsules:…
Questions to Ask a Bariatric Surgeon (and How to Check Credentials)The questions to ask a bariatric surgeon and how to check credentials: American Board of Surgery…
10 Best Walking and Step-Counter Apps (2026)The 10 best walking and step-counter apps for 2026, ranked by the step-count evidence, self-monitoring features,…Questions to ask a professional
- Given my health, would you suggest a behavioral program, a medical program, or both?
- Do I have any condition that would make a low-calorie program or a medication unsafe for me?
- Is there a covered program, such as Medicare counseling or an employer plan, I could use first?
- How will we measure progress, and when should we change the plan?
- What is my plan for keeping the weight off?
Frequently asked questions
What is the difference between a medical and a commercial weight-loss program?
A commercial program sells food, an app, coaching or group support. A medical program is led by licensed clinicians who evaluate you, can manage related conditions and may prescribe medication or refer for surgery.
Which works better?
They are not directly comparable. Medicines produced larger average weight loss in trials, but with more cost and side effects; behavioral programs have smaller average effects with very low risk. The right choice depends on your health and goals, decided with a clinician.
Do commercial programs like WeightWatchers really work?
Yes, modestly. A 2015 review found WeightWatchers led to at least 2.6% and Jenny Craig at least 4.9% more weight loss than control at 12 months.
Is medical weight loss covered by insurance?
Visits with your doctor may be covered, and Medicare covers behavioral counseling for a BMI of 30 or more. Medication coverage varies; Medicare's GLP-1 Bridge runs from July 2026 to December 2027.
Can I do both?
Yes. Weight-loss medicines are FDA approved for use together with a reduced-calorie diet and more activity, and several commercial programs now have a medical tier.
Who qualifies for weight-loss medication?
Only a clinician can decide that. The NIH says weight-management medicines are generally considered for adults with a BMI of 30 or more, or 27 or more with a weight-related condition; each FDA label adds its own criteria and cautions.
How much does each route cost?
On 2026-10-06, app programs cost about $12-$70 a month, telehealth memberships $74-$149 a month, and brand GLP-1s $149-$449 a month at manufacturer self-pay prices.
What happens when I stop a program or a medication?
Weight regain is common on both routes. In the STEP 1 extension, people regained about two thirds of the weight lost within a year of stopping Wegovy. Plan maintenance from the start.
References
- Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions. U.S. Preventive Services Task Force, 2018. (accessed October 7, 2026) Guideline
- Choosing a Safe & Successful Weight-loss Program. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). (accessed October 7, 2026) Government page
- Diabetes Prevention Program (DPP). National Institute of Diabetes and Digestive and Kidney Diseases (NIH). (accessed October 6, 2026) Government page
- Gudzune KA, Doshi RS, Mehta AK, et al.. Efficacy of commercial weight-loss programs: an updated systematic review. Annals of Internal Medicine, 2015. doi:10.7326/M14-2238 · PMID 25844997 (accessed October 7, 2026) Meta-analysis
- Jebb SA, Ahern AL, Olson AD, et al.. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. The Lancet, 2011. doi:10.1016/S0140-6736(11)61344-5 · PMID 21906798 (accessed October 7, 2026) Randomized trial
- Rock CL, Flatt SW, Sherwood NE, et al.. Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women. JAMA, 2010. doi:10.1001/jama.2010.1503 · PMID 20935338 · NCT00640900 (accessed October 7, 2026) Randomized trial
- Arterburn LM, Coleman CD, Kiel J, et al.. Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obesity Science and Practice, 2019. doi:10.1002/osp4.312 · PMID 30820327 (accessed October 6, 2026) Randomized trial
- Wilding JPH, Batterham RL, Calanna S, et al.. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021. doi:10.1056/NEJMoa2032183 · PMID 33567185 · NCT03548935 (accessed October 7, 2026) Randomized trial
- Jastreboff AM, Aronne LJ, Ahmad NN, et al.. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022. doi:10.1056/NEJMoa2206038 · PMID 35658024 · NCT04184622 (accessed October 7, 2026) Randomized trial
- Wharton S, Lingvay I, Bogdanski P, et al.. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). New England Journal of Medicine, 2025. doi:10.1056/NEJMoa2500969 · PMID 40934115 · NCT05564117 (accessed October 6, 2026) Randomized trial
- Wilding JPH, Batterham RL, Davies M, et al.. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022. doi:10.1111/dom.14725 · PMID 35441470 (accessed October 7, 2026) Randomized trial
- Prescription Medications to Treat Overweight & Obesity. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). (accessed October 7, 2026) Government page
- WEGOVY (semaglutide) injection and tablets: prescribing information. Novo Nordisk, via DailyMed, 2026. (accessed October 7, 2026) Drug label
- Obesity behavioral therapy. Medicare.gov. (accessed October 6, 2026) Government page
- Medicare GLP-1 Bridge. Centers for Medicare & Medicaid Services. (accessed October 6, 2026) Government page
- Publication 502 (2025), Medical and Dental Expenses. Internal Revenue Service, 2025. (accessed October 6, 2026) Government page
- How much does Noom Weight cost in 2026?. Noom, Inc., 2026. (accessed October 7, 2026) Other
- WeightWatchers Med+. WW International, Inc.. (accessed October 6, 2026) Other
- WeightWatchers plans and pricing. WW International, Inc.. (accessed October 6, 2026) Other
- Ro Body Membership (capture, 2026-10-03). Ro, via Internet Archive, 2026. (accessed October 6, 2026) Other
- Hims weight loss (capture, 2026-10-01). Hims & Hers Health, Inc., via Internet Archive, 2026. (accessed October 6, 2026) Other
- Wegovy at NovoCare Pharmacy: self-pay prices. Novo Nordisk (NovoCare Pharmacy). (accessed October 7, 2026) Other
- Zepbound coverage and savings. Eli Lilly and Company. (accessed October 6, 2026) Other
Facts checked on October 6, 2026
Educational information, not medical advice. Talk with a qualified healthcare professional about your own situation. In an emergency call 911.